Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders DOI Open Access
Hironori Tsuchiya

Published: April 13, 2023

Since the worldwide spread of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), treating taste and saliva secretory disorders associated disease 2019 (COVID-19) has become one most critical issues in COVID-19 era. The aim present study was to update information on treatments being applicable such oral symptoms discuss their pathogenic mechanisms. Promising include different types methods using tetracycline, corticosteroid, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drug, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion. At present, however, fully validated are still lacking for COVID-19-associated ageusia/dysgeusia/hypogeusia xerostomia/dry mouth/hyposalivation. An appropriately selected treatment healthcare should be provided patients survivors suffering from disorders. Understanding currently available options is required dental profes-sionals because they not only experience who were infected SARS-CoV-2 or recov-ered but first aware abnormal salivary secretion. By doing so, dentists hygienists can play a crucial role managing contribute improving health-related quality life relevant patients.

Language: Английский

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders DOI Creative Commons
Hironori Tsuchiya

Dentistry Journal, Journal Year: 2023, Volume and Issue: 11(6), P. 140 - 140

Published: May 25, 2023

Since the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, treating taste and saliva secretory disorders associated with disease 2019 (COVID-19) has become a critical issue. The aim present study was to update information on treatments applicable such oral symptoms discuss their pathogenic mechanisms. literature search indicated that different using tetracycline, corticosteroids, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drugs, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion have potential effects COVID-19-associated ageusia/dysgeusia/hypogeusia xerostomia/dry mouth/hyposalivation. These multiple modes action viral cellular entry replication, cell proliferation differentiation, immunity, SARS-CoV-2 infection-induced pathological conditions as inflammation, cytokine storm, pyroptosis, neuropathy, zinc dyshomeostasis, dysautonomia. An understanding currently available treatment options is required for dental professionals because they may treat patients who were infected or recovered from COVID-19, aware abnormal salivary secretion. By doing so, dentists hygienists could play crucial role in managing COVID-19 contribute improving health-related quality life relevant patients.

Language: Английский

Citations

6
Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders DOI Open Access
Hironori Tsuchiya

Published: April 13, 2023

Since the worldwide spread of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), treating taste and saliva secretory disorders associated disease 2019 (COVID-19) has become one most critical issues in COVID-19 era. The aim present study was to update information on treatments being applicable such oral symptoms discuss their pathogenic mechanisms. Promising include different types methods using tetracycline, corticosteroid, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drug, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion. At present, however, fully validated are still lacking for COVID-19-associated ageusia/dysgeusia/hypogeusia xerostomia/dry mouth/hyposalivation. An appropriately selected treatment healthcare should be provided patients survivors suffering from disorders. Understanding currently available options is required dental profes-sionals because they not only experience who were infected SARS-CoV-2 or recov-ered but first aware abnormal salivary secretion. By doing so, dentists hygienists can play a crucial role managing contribute improving health-related quality life relevant patients.

Language: Английский

Citations

2
Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders DOI Open Access
Hironori Tsuchiya

Published: April 14, 2023

Since the worldwide spread of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), treating taste and saliva secretory disorders associated disease 2019 (COVID-19) has become one most critical issues in COVID-19 era. The aim present study was to update information on treatments being applicable such oral symptoms discuss their pathogenic mechanisms. Promising include different types methods using tetracycline, corticosteroid, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drug, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion. At present, however, fully validated are still lacking for COVID-19-associated ageusia/dysgeusia/hypogeusia xerostomia/dry mouth/hyposalivation. An appropriately selected treatment healthcare should be provided patients survivors suffering from disorders. Understanding currently available options is required dental profes-sionals because they not only experience who were infected SARS-CoV-2 or recov-ered but first aware abnormal salivary secretion. By doing so, dentists hygienists can play a crucial role managing contribute improving health-related quality life relevant patients.

Language: Английский

Citations

2
Diode laser in management of loss of taste sensation in patients with post-COVID syndrome: a randomized clinical trial DOI Creative Commons
Alshaimaa Ahmed Shabaan, Islam Kassem, Aliaa Mahrous

et al.

BMC Oral Health, Journal Year: 2023, Volume and Issue: 23(1)

Published: May 6, 2023

Abstract Objective Loss of taste (ageusia) is a symptom observed following recovery from COVID-19 infection. The loss and smell sensation may negatively affect patients’ quality life (QoL). present study aimed to evaluate the effectiveness Diode Laser in managing patients with post-COVID syndrome versus placebo. Material method sample was 36 who complained persistent COVID-19. were randomly assigned one two groups according received treatment: Group I (laser treatment) II (light treatment), each patient receiving diode laser treatment or placebo same operator. Taste subjectively measured after for four weeks. Results results demonstrated significant difference between both regarding restoration month (p = 0.041), having significantly higher percentage cases 7 (38.9%) partial restoration. In contrast, proportion 17 (94.4%) had complete < 0.001). Conclusion concluded that using 810 nm aided more rapid dysfunction.

Language: Английский

Citations

2
Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders DOI Open Access
Hironori Tsuchiya

Published: April 13, 2023

Since the worldwide spread of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), treating taste and saliva secretory disorders associated disease 2019 (COVID-19) has become one most critical issues in COVID-19 era. The aim present study was to update information on treatments being applicable such oral symptoms discuss their pathogenic mechanisms. Promising include different types methods using tetracycline, corticosteroid, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drug, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion. At present, however, fully validated are still lacking for COVID-19-associated ageusia/dysgeusia/hypogeusia xerostomia/dry mouth/hyposalivation. An appropriately selected treatment healthcare should be provided patients survivors suffering from disorders. Understanding currently available options is required dental profes-sionals because they not only experience who were infected SARS-CoV-2 or recov-ered but first aware abnormal salivary secretion. By doing so, dentists hygienists can play a crucial role managing contribute improving health-related quality life relevant patients.

Language: Английский

Citations

1
Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders DOI Open Access
Hironori Tsuchiya

Published: April 13, 2023

Since the worldwide spread of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), treating taste and saliva secretory disorders associated disease 2019 (COVID-19) has become one most critical issues in COVID-19 era. The aim present study was to update information on treatments being applicable such oral symptoms discuss their pathogenic mechanisms. Promising include different types methods using tetracycline, corticosteroid, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drug, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion. At present, however, fully validated are still lacking for COVID-19-associated ageusia/dysgeusia/hypogeusia xerostomia/dry mouth/hyposalivation. An appropriately selected treatment healthcare should be provided patients survivors suffering from disorders. Understanding currently available options is required dental profes-sionals because they not only experience who were infected SARS-CoV-2 or recov-ered but first aware abnormal salivary secretion. By doing so, dentists hygienists can play a crucial role managing contribute improving health-related quality life relevant patients.

Language: Английский

Citations

1